[HTML][HTML] Convalescent plasma treatment of severe COVID-19: a propensity score–matched control study
…, D Rodriguez, P Tandon, A Bassily-Marcus, J Bander… - Nature medicine, 2020 - nature.com
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), is a new human disease with few effective treatments 1 . …
coronavirus 2 (SARS-CoV-2), is a new human disease with few effective treatments 1 . …
Clinical Implications of SARS-CoV-2 Interaction With Renin Angiotensin System: JACC Review Topic of the Week
…, J Narula, R Shimony, J Bander - Journal of the American …, 2020 - jacc.org
Severe acute respiratory-syndrome coronavirus-2 (SARS-CoV-2) host cell infection is
mediated by binding to angiotensin-converting enzyme 2 (ACE2). Systemic dysregulation …
mediated by binding to angiotensin-converting enzyme 2 (ACE2). Systemic dysregulation …
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3 …
…, D Hotchkiss, M Abu-Fadel, A Wiseman, J Bander… - The Lancet, 2019 - thelancet.com
Background Patients with stable coronary artery disease and diabetes with previous
percutaneous coronary intervention (PCI), particularly those with previous stenting, are at high risk …
percutaneous coronary intervention (PCI), particularly those with previous stenting, are at high risk …
[HTML][HTML] Comorbidities, sequelae, blood biomarkers and their associated clinical outcomes in the Mount Sinai Health System COVID-19 patients
With the continuing rise of SARS-CoV2 infection globally and the emergence of various
waves in different countries, understanding characteristics of susceptibility to infection, clinical …
waves in different countries, understanding characteristics of susceptibility to infection, clinical …
[HTML][HTML] Retrospective analysis of demographic factors in COVID-19 patients entering the Mount Sinai Health System
With the continued rise of the global incidence of COVID-19 infection and emergent second
wave, the need to understand characteristics that impact susceptibility to infection, clinical …
wave, the need to understand characteristics that impact susceptibility to infection, clinical …
Combined and independent impact of diabetes mellitus and chronic kidney disease on residual platelet reactivity
U Baber, J Bander, R Karajgikar… - Thrombosis and …, 2013 - thieme-connect.com
Patients with both chronic kidney disease (CKD) and diabetes mellitus (DM) are at increased
risk for thrombotic events compared to those with one abnormality alone. Whether this can …
risk for thrombotic events compared to those with one abnormality alone. Whether this can …
Outcomes of Impella‐supported high‐risk nonemergent percutaneous coronary intervention in a large single‐center registry
L Azzalini, GS Johal, U Baber, J Bander… - Catheterization and …, 2021 - Wiley Online Library
Objectives We aimed to evaluate the early and one‐year outcomes of Impella‐supported
high‐risk nonemergent percutaneous coronary intervention (PCI). Background The evidence …
high‐risk nonemergent percutaneous coronary intervention (PCI). Background The evidence …
[HTML][HTML] New methodologies to accurately assess circulating active transforming growth factor-β1 levels: implications for evaluating heart failure and the impact of left …
…, J Monteagudo, M Suárez-Fariñas, J Bander… - Translational …, 2018 - Elsevier
Transforming growth factor-β1 (TGF-β1) has been used as a biomarker in disorders associated
with pathologic fibrosis. However, plasma TGF-β1 assessment is confounded by the …
with pathologic fibrosis. However, plasma TGF-β1 assessment is confounded by the …
Changes in von Willebrand factor-cleaving protease (ADAMTS-13) in patients with aortic stenosis undergoing valve replacement or balloon valvuloplasty
J Bander, S Elmariah, LM Aledort, J Dlott… - Thrombosis and …, 2012 - thieme-connect.com
It was the objective of this study to determine whether reduced cleavage of von Willebrand
factor (VWF) multimers following aortic valve replacement (AVR) is a consequence of reduced …
factor (VWF) multimers following aortic valve replacement (AVR) is a consequence of reduced …
[HTML][HTML] An allele-specific PCR system for rapid detection and discrimination of the CYP2C19∗ 4A,∗ 4B, and∗ 17 alleles: implications for clopidogrel response testing
CYP2C19 is involved in the metabolism of clinically relevant drugs, including the antiplatelet
prodrug clopidogrel, which has prompted interest in clinical CYP2C19 genotyping. The …
prodrug clopidogrel, which has prompted interest in clinical CYP2C19 genotyping. The …
